Patients with atrophic gastritis with intestinal metaplasia do not need to take long-term medication if they do not develop cancer and improve after active treatment; patients who develop cancer may need long-term treatment.
Patients with atrophic gastritis with intestinal metaplasia need to follow the doctor’s instruction to take active treatment if there is no cancer, such as patients with gastric mucous membrane erosion or with acid reflux and heartburn symptoms can take ranitidine and cimetidine for treatment; patients with gastric mucous membrane erosion can take Rebapente for treatment, and patients with Helicobacter pylori infection can take metronidazole and other medications for treatment. Those who have improved after treatment generally do not need to take long-term medication.
When atrophic gastritis with enterocolitis develops further and causes cancer, it is necessary to consider surgical resection, and if necessary, it is also necessary to carry on chemotherapy after surgery, such as fluorouracil combined with platinum and so on, and this kind of situation may need long-term drug treatment.
Patients with atrophic gastritis with enterocolitis should actively cooperate with their doctors and maintain a healthy lifestyle, which will help improve the prognosis.